Thane: Specialty chemical manufacturer Neogen Chemicals has witnessed a 22% rise in revenues to ₹247 crore for Q4 FY26 despite supply chain disruptions and geopolitical challenges. The company utilized its robust volume growth and high plant efficiency to unlock bottom line growth.
This has meant its consolidated net profit for Q4 has risen 373% from the same period last year to ₹11 crore, with its EBITDA rising 21% to ₹44 crore as well. The company’s robust profitability has come at a time even after a fire was reported at its Dahej facility, with the company deploying capex to rebuild it.
The Thane-based company has also announced a ₹1/share final dividend for its shareholders as well.
“Demonstrating strong operational resilience, our Q4 & FY26 performance was robust against a challenging geopolitical backdrop. Growth was driven by high plant throughput and stable demand visibility across both our core and emerging applications. Input cost inflation, including packaging materials, remains mostly a pass-through for us, ensuring our core profitability remains protected. Underscoring our conviction in Neogen’s long-term growth trajectory and our strategic pivot into high-growth segments, the promoters have infused INR 161 crore of capital to support our expansion plans.
In Battery Materials, Neogen Ionics continues to strengthen its position as one of the most reliable player within India’s evolving lithium-ion battery materials ecosystem, that aligns with India’s ‘Atmanirbhar Bharat’ vision. The Pakhajan Greenfield Project timelines remain unchanged (H1 FY27 for Electrolyte and H2 FY27 for Electrolyte Salts) and the specialized MUIS Electrolyte plant has successfully initiated the trial-run phase to ensure process stabilization. Our immediate focus centers on phased capacity ramp-up and customer qualification. Encouragingly, for Electrolyte Salts, provisional approvals have already been received from additional international customers, and final site audits are actively underway to transition them to commercial-ready supplies.
Looking ahead, FY27 is expected to be a transformative year for Neogen as we commission one of India’s largest greenfield facilities dedicated to Battery Materials at Pakhajan. Simultaneously, Neogen Ionics’ Dahej plant also received 3 US-based electrolyte makers audit approval and will also scale up this year supported by improving demand visibility. Furthermore, our standalone operations are set to resume a normalized growth trajectory, aided by the replacement plant at Dahej expected to be commissioned by June 2026. Backed by these growth drivers, we remain confident of achieving revenues in the range of INR 875– 950 crore in FY27, at standalone basis considering MPP-5 full production from Q2 FY26.” Dr. Harin Kanani, Managing Director, Neogen Chemicals, said in a press release.
